The mission of Emerging Microbes & Infections (EMI) is to provide a new integrated forum to allow for the timely dissemination of large amount of information gathered about microbes and infections, especially ones associated with increasing biological and clinical significance and pathogenic frequency.
As an Open Access journal, all articles in EMI are fully downloadable. Browse some of our most read recent articles below.
|Antibodies in the breast milk of a maternal woman with COVID-19||Yunzhu Dong et al.|
|Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?||Jean-Marie Berthelot et al.|
|Serological differentiation between COVID-19 and SARS infections||Wan Ni Chia et al.|
|Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus||Anges Yadouleton et al.|
|Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients||Cristina Andrés et al.|
|A serological survey of SARS-CoV-2 in cat in Wuhan||Qiang Zhang et al.|
EMI will serve microbiologists, clinicians, public health workers, drug and vaccine developers, as well as policy makers by providing them with updated knowledge encompassing microbes and infections emerging in different countries and regions throughout the world. 2018 Impact Factor: 6.212